RYGNAR
Live / Applied — Second extension granted (statement of use) (as of 30 Sept 2025)
What this means for you
Not registered yet, but its 22 Dec 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98328532
- Mark type
- Stylized text
- Filed
- 22 Dec 2023
- Published for opposition
- 03 Sept 2024
- Attorney of record
- Sarah P. Harrell
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; therapeutic vaccines; therapeutic vaccines for the treatment of Human Papilloma Virus (HPV) and HPV-related disorders and diseases, in particular disorders and diseases caused by one or both of HPV 6 and HPV 11, including Recurrent Respiratory Papillomatosis (RRP); pharmaceutical preparations and substances for the treatment of Human Papilloma Virus (HPV) and HPV-related disorders and diseases, in particular disorders and diseases caused by one or both of HPV 6 and HPV 11, including Recurrent Respiratory Papillomatosis (RRP)
Owner
- Precigen, Inc., Germantown, MD, US
- Precigen, Inc., Germantown, MD, US
Prosecution history
- 01 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Sept 2025 — SOU EXTENSION 2 GRANTED
- 30 Sept 2025 — SOU EXTENSION 2 FILED
- 30 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 28 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Mar 2025 — SOU EXTENSION 1 GRANTED
- 28 Mar 2025 — SOU EXTENSION 1 FILED
- 28 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 29 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Sept 2024 — PUBLISHED FOR OPPOSITION
- 14 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Jul 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Jul 2024 — ASSIGNED TO EXAMINER
- 05 Apr 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED